Loading...
•
May 31, 2020
Neogen Q4 2020 Earnings Report
Neogen's Q4 2020 financial results were announced, revealing a slight decrease in revenue but an increase in net income compared to the prior year quarter.
Key Takeaways
Neogen Corporation reported Q4 2020 revenues of $109.07 million, a slight decrease from $109.76 million in the prior year quarter. Net income increased to $16.35 million, or $0.31 per share, compared to $15.82 million, or $0.30 per share, in the prior year quarter. The company's performance was impacted by currency headwinds and disruptions in the global food supply, but was supported by opportunistic sales of sanitizers and disinfectants and continued strength in genomic service revenues.
Q4 revenue was $109.07 million, slightly down from $109.76 million in the prior year quarter.
Net income for Q4 was $16.35 million, or $0.31 per share, up from $15.82 million, or $0.30 per share, in the prior year quarter.
Gross margins improved to 47.4% due to sanitizer sales and genomic service revenues.
Operating income increased to $19.94 million, or 18.3% of sales, compared to $18.73 million, or 17.1% of sales, in the prior year quarter.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...